These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12455410)

  • 21. Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.
    Kehlenbeck S; Betz U; Birkmann A; Fast B; Göller AH; Henninger K; Lowinger T; Marrero D; Paessens A; Paulsen D; Pevzner V; Schohe-Loop R; Tsujishita H; Welker R; Kreuter J; Rübsamen-Waigmann H; Dittmer F
    J Virol; 2006 Jul; 80(14):6883-94. PubMed ID: 16809294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to inhibitors of the human immunodeficiency virus type 1 integration.
    Hazuda DJ
    Braz J Infect Dis; 2010; 14(5):513-8. PubMed ID: 21221483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agents.
    de Soultrait VR; Lozach PY; Altmeyer R; Tarrago-Litvak L; Litvak S; Andréola ML
    J Mol Biol; 2002 Nov; 324(2):195-203. PubMed ID: 12441099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human immunodeficiency virus type 1 integration by diketo derivatives.
    Pluymers W; Pais G; Van Maele B; Pannecouque C; Fikkert V; Burke TR; De Clercq E; Witvrouw M; Neamati N; Debyser Z
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3292-7. PubMed ID: 12234864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nef expressed from human immunodeficiency virus type 1 extrachromosomal DNA downregulates CD4 on primary CD4+ T lymphocytes: implications for integrase inhibitors.
    Gillim-Ross L; Cara A; Klotman ME
    J Gen Virol; 2005 Mar; 86(Pt 3):765-771. PubMed ID: 15722538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diketo acids derivatives as integrase inhibitors: the war against the acquired immunodeficiency syndrome.
    Henao-Mejia J; Góez Y; Patiño P; Rugeles MT
    Recent Pat Antiinfect Drug Discov; 2006 Jun; 1(2):255-65. PubMed ID: 18221151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diketoacid chelating ligands as dual inhibitors of HIV-1 integration process.
    Rogolino D; Carcelli M; Compari C; De Luca L; Ferro S; Fisicaro E; Rispoli G; Neamati N; Debyser Z; Christ F; Chimirri A
    Eur J Med Chem; 2014 May; 78():425-30. PubMed ID: 24704615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunodeficiency virus type 1 (HIV-1) integrase: resistance to diketo acid integrase inhibitors impairs HIV-1 replication and integration and confers cross-resistance to L-chicoric acid.
    Lee DJ; Robinson WE
    J Virol; 2004 Jun; 78(11):5835-47. PubMed ID: 15140981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships of HIV-1 integrase inhibitors--enzyme-ligand interactions.
    Maurin C; Bailly F; Cotelle P
    Curr Med Chem; 2003 Sep; 10(18):1795-810. PubMed ID: 12871105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.
    Christ F; Debyser Z
    Virology; 2013 Jan; 435(1):102-9. PubMed ID: 23217620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-HIV-1 integrase drugs: how far from the shelf?
    Pani A; Marongiu ME
    Curr Pharm Des; 2000 Mar; 6(5):569-84. PubMed ID: 10788597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1.
    Cherepanov P; Esté JA; Rando RF; Ojwang JO; Reekmans G; Steinfeld R; David G; De Clercq E; Debyser Z
    Mol Pharmacol; 1997 Nov; 52(5):771-80. PubMed ID: 9351967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.
    Robinson WE; Cordeiro M; Abdel-Malek S; Jia Q; Chow SA; Reinecke MG; Mitchell WM
    Mol Pharmacol; 1996 Oct; 50(4):846-55. PubMed ID: 8863829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitors of HIV-1 entry and integration: recent developments and impact on treatment.
    Sharma AK; George V; Valiathan R; Pilakka-Kanthikeel S; Pallikkuth S
    Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):151-61. PubMed ID: 23578097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
    Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In search of second-generation HIV integrase inhibitors: targeting integration beyond strand transfer.
    Voet AR; Maeyer MD; Debyser Z; Christ F
    Future Med Chem; 2009 Oct; 1(7):1259-74. PubMed ID: 21426102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New class of HIV integrase inhibitors that block viral replication in cell culture.
    Pannecouque C; Pluymers W; Van Maele B; Tetz V; Cherepanov P; De Clercq E; Witvrouw M; Debyser Z
    Curr Biol; 2002 Jul; 12(14):1169-77. PubMed ID: 12176326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New developments in diketo-containing inhibitors of HIV-1 integrase.
    Zhao G; Wang C; Liu C; Lou H
    Mini Rev Med Chem; 2007 Jul; 7(7):707-25. PubMed ID: 17627583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical evaluation of 1H-benzylindole derivatives as novel human immunodeficiency virus integrase strand transfer inhibitors.
    Hombrouck A; Van Remoortel B; Michiels M; Noppe W; Christ F; Eneroth A; Sahlberg BL; Benkestock K; Vrang L; Johansson NG; Barreca ML; De Luca L; Ferro S; Chimirri A; Debyser Z; Witvrouw M
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2861-9. PubMed ID: 18541726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a human immunodeficiency virus vector-based, single-cycle assay for evaluation of anti-integrase compounds.
    Bona R; Andreotti M; Buffa V; Leone P; Galluzzo CM; Amici R; Palmisano L; Mancini MG; Michelini Z; Di Santo R; Costi R; Roux A; Pommier Y; Marchand C; Vella S; Cara A
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3407-17. PubMed ID: 17005823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.